SomnoMed Limited (FRA:RJV)

Market Cap	44.47M -48.8%
Revenue (ttm)	67.32M +18.2%
Net Income	-1.45M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	15.88
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.2060
Previous Close	0.2020
Day's Range	0.2060 - 0.2060
52-Week Range	0.1960 - 0.5000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SomnoMed

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper te...

• Industry: Dental Equipment and Supplies
• Founded: 1987
• Employees: 300
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RJV

Financial Performance

In fiscal year 2025, SomnoMed's revenue was 111.49 million, an increase of 21.65% compared to the previous year's 91.65 million. Losses were -3.46 million, -71.77% less than in 2024.

Financial numbers in AUD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error